Skip to main content
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: Mol Carcinog. 2018 Jun 28;57(10):1300–1310. doi: 10.1002/mc.22844

Figure 2. AKR1B10 increases DAG levels in breast cancer cells.

Figure 2.

DAG and subspecies were measured quantitatively by liquid chromatography-mass spectrum as described in Methods and Materials. (A) Total DAG levels in MCF-7 cells with AKR1B10 expression (left) and BT-20 cells and HCT-8 cells with AKR1B10 silencing (right). (B) Levels of various subspecies of DAG in MCF-7 (upper), BT-20 (lower left) and HCT-8 (lower right) cells. Y axis is in log10. IS, internal standard. *, p<0.05 and **, p<0.01 when compared to vector control.